Authors: Curtis, SP Eardley, I Boyce, M Larson, P Haesen, R Gottesdiener, K Gertz, BJ

Citation: Sp. Curtis et al., Single dose methodology to assess the influence of an alpha(1)-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia, BR J CL PH, 49(3), 2000, pp. 269-273

Authors: Schwartz, JI Bugianesi, KJ Ebel, DL De Smet, M Haesen, R Larson, PJ Ko, A Verbesselt, R Hunt, TL Lins, R Lens, S Porras, AG Dieck, J Keymeulen, B Gertz, BJ

Citation: Ji. Schwartz et al., The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin, CLIN PHARM, 68(6), 2000, pp. 626-636

Authors: Knorr, B Larson, P Nguyen, HH Holland, S Reiss, TF Chervinsky, P Blake, K van Nispen, CHM Noonan, G Freeman, A Haesen, R Michiels, N Rogers, JD Amin, RD Zhao, J Xu, X Seidenberg, BC Gertz, BJ Spielberg, S

Citation: B. Knorr et al., Montelukast dose selection in 6-to 14-year-olds: Comparison of single-dosepharmacokinetics in children and adults, J CLIN PHAR, 39(8), 1999, pp. 786-793